Trusted by 100,000+ International Patients
Brain Cancer Treatment: India vs Vietnam
Cost, Quality & Recovery Compared
$7500
India Starting Cost
$8000
Vietnam Starting Cost
See how these top medical tourism destinations compare for Brain Cancer Treatment.
| Comparison Factor | India | Vietnam | Winner |
|---|---|---|---|
| Average Cost (in USD) | 7500 - 12000 | 8000 - 20000 | India |
| Success Rate (Min and Max) | 85% disease control benchmarks | 70% – 88% | India |
| Advanced Technology | Neuronavigation and intraoperative monitoring in tertiary centres; availability of advanced radiotherapy and SRS; chemotherapy and supportive neuro-oncology services. | Advanced neuro-oncology services, including neuronavigation, intraoperative imaging (CT/MRI in select centres), stereotactic radiosurgery (Gamma Knife), IMRT, VMAT, and growing adoption of molecular diagnostics and targeted therapy in major hospitals | Both Equal |
| JCI Accredited Hospitals | 40+ | 2–4 | India |
| Visa Process | Medical Visa (3–7 working days) | Medical Visa / E-visa / Tourist Visa (3–7 working days) | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth India and Vietnam maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
40+ JCI-accredited hospitals with additional NABH accreditation across leading oncology and neurosurgery centres.
Leading cancer centres report strong surgical outcomes and survival rates supported by multidisciplinary neuro-oncology care.
Advanced oncology hospitals achieve high treatment success through integrated expertise in surgery and radiotherapy.
Vietnam has a growing number of internationally aligned hospitals, with select institutions holding JCI accreditation and many adhering to Ministry of Health standards and global oncology protocols.
Good clinical outcomes in brain tumour management, especially for common and operable tumours, are supported by improving surgical expertise, access to radiotherapy, and multidisciplinary care in leading centres.
Healthcare is regulated by the Vietnamese Ministry of Health, ensuring compliance with national clinical standards, patient safety protocols, and gradual alignment with international oncology care guidelines.
| Quality Metric | India | Vietnam |
|---|---|---|
Accredited Hospitals | 40+ | 2–4 |
Average Success Rate | 70%-90% | 70% – 88% |
Advanced RT (IMRT/VMAT/SRS) | Yes (major centres) | Available in major cancer centres (IMRT/VMAT/SRS) |
Neuronavigation Availability | Yes (tertiary) | Available in leading tertiary hospitals |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Dedicated neuro-oncology programs integrating neurosurgery, radiation oncology, and medical oncology for comprehensive brain tumor management.
Advanced neuro-oncology centres combining neurosurgery, stereotactic radiosurgery, and oncology care within multidisciplinary hospital systems.
Skilled neurosurgeons and neuro-oncologists experienced in brain tumour surgeries, stereotactic procedures, and integrated oncology care.
Moderate-to-high patient volumes in major urban centres with increasing experience in complex brain tumour cases and adoption of advanced techniques.
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Tertiary hospitals are equipped with neuronavigation systems, intraoperative MRI/CT, advanced ICUs, and modern radiotherapy units.
Luxury healthcare experience
Moderate-to-high patient volumes in major urban centres with increasing experience in complex brain tumour cases and adoption of advanced techniques.
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after Brain Cancer Treatment in both countries.
Patients remain hospitalised for brain tumour surgery or therapy, post-operative monitoring, and early neurological recovery care.
Recommended local stay: 10–14 days for recovery, review, and RT planning, if needed.
Often 3–4 weeks post-surgery, depending on stability and ongoing RT schedule.
Surgical recovery 6–8 weeks; oncology treatment course may extend 2–6+ months.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
Patients remain hospitalised for brain tumour surgery or therapy, post-operative monitoring, and early neurological recovery care.
Recommended local stay: 10–14 days for recovery, review, and RT planning, if needed.
Often 3–4 weeks post-surgery, depending on stability and ongoing RT schedule.
Surgical recovery 6–8 weeks; oncology treatment course may extend 2–6+ months.
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
Brain Cancer Treatment recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your Brain Cancer Treatment journey.
Recognised neurosurgical risks; minimised via ICU monitoring and protocols.
Edema and headaches are possible; steroids and monitoring are used.
Depends on wound healing and neurological status; rehab may be needed.
Neurological deficits, seizures, CSF leak; risks depend on tumor location
Steroids can cause metabolic effects; anti-seizure meds can cause drowsiness; monitored.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Ideal candidates include patients with resectable brain tumors or those needing biopsy and integrated neuro-oncology care, including RT/chemo.
Ideal candidates include patients with resectable brain tumors or those needing biopsy and integrated neuro-oncology care, including RT/chemo.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your Brain Cancer Treatment journey.
Verify tumor type and grade through MRI and biopsy to determine the appropriate neuro-oncology treatment plan.
Select a specialised centre with experienced neurosurgeons and neuro-oncology teams for complex brain tumor management.
Coordinate radiotherapy and chemotherapy schedules, as these treatments often continue for several weeks.
Coordinate radiotherapy and chemotherapy schedules, as these treatments often continue for several weeks.
Schedule regular MRI scans after treatment to monitor recovery and detect any recurrence early.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
